arterial hypertension

New insights in the treatment strategy for pulmonary arterial hypertension.

If the lungs are involved it is usually in the form of pulmonary arterial hypertension.

In addition, it has little effect on blood pressure, while vasopressin may cause arterial hypertension.

Arterial hypertension is a diagnostic requirement, but may be mild.

Arterial hypertension can be an indicator of other problems and may have long-term adverse effects.

His situation complicated because of an arritmia, the diabetes and arterial hypertension.

Right heart failure is the principal consequence of pulmonary arterial hypertension.

This leads to a similar pathophysiology as pulmonary arterial hypertension.

The disease, also called pulmonary arterial hypertension, can make even routine tasks an ordeal.

When there is no apparent cause, it's called idiopathic pulmonary arterial hypertension.

If no cause can be identified, the condition is called idiopathic pulmonary arterial hypertension.

Task force 1: Mapping the arterial hypertension prevalence on the continent and make predictions for near future.

Heightened sensitivity of neurological response systems leading to arterial hypertension is also possible, but has not been examined.

Arterial hypertension in the arms with normal to low blood pressure in the lower extremities is classic.

The dosage for pulmonary arterial hypertension (Revatio) is three times a day.

Iloprost is used as an inhalant to treat pulmonary arterial hypertension.

Increased afterload may be found in aortic stenosis and arterial hypertension.

It leads to arterial hypertension (high blood pressure) associated with hypokalemia, usually a diagnostic clue.

A pheochromocytoma can also cause resistant arterial hypertension.

In May 2008, terguride was granted orphan drug status for the treatment of pulmonary arterial hypertension.

Common cardiovascular problems related to this syndrome are cardiac hypertrophy and arterial hypertension (high blood pressure).

The approved dose for pulmonary arterial hypertension is 40 mg (two 20-mg tablets) once daily.

Macitentan is an investigational drug being studied for the treatment of pulmonary arterial hypertension.

Interestingly, similar findings were recently described for pulmonary arterial hypertension [18].

Pulmonary arterial hypertension can be caused by lung disease, autoimmune disease, or heart failure.